< Back to search
Filter
1

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting
Featured

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

for
Multiple Myeloma
Location: New York NY, Fairfax VA, Chapel Hill NC, Roanoke VA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07095452

Phase2, Phase3, Recruiting
Featured

A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Tampa FL, Newnan GA, Grand Rapids MI, Denver CO,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07409246

Phase1, Recruiting
Featured

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: New York NY, New Brunswick NJ, Montreal,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06896916

Phase1, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

for
Multiple Myeloma
Location: New York NY, Chapel Hill NC, Winston-Salem NC,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06892522

Phase1, Phase2, Recruiting

Interested in new multiple sclerosis trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Microelectrode Recordings From the Vagus Nerve in Awake Humans

for
Epilepsy
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 18 - 40

Code: NCT06016686

Phase1, Recruiting
New

A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice

for
Multiple Sclerosis
Location: East Hanover NJ
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07779460

Recruiting

Fall Risk Reduction in Multiple Sclerosis (FIRMS)

for
Multiple Sclerosis
Location: Urbana IL
Sponsor: University of Illinois at Urbana-Champaign

Sex: All

Age: 18 - 64

Code: NCT02314585

Recruiting

Physiology of Interregional Connectivity in the Human Brain

for
Healthy, Stroke, Traumatic Brain Injury, Multiple Sclerosis
Location: Chicago IL
Sponsor: Shirley Ryan AbilityLab

Sex: All

Age: 18 - 70+

Code: NCT03723434

Recruiting

A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets

for
Multiple Sclerosis
Location: Latham NY
Sponsor: Keith Edwards, M.D.

Sex: All

Age: 21 - 65

Code: NCT04550455

Recruiting

Effects of Spinal Cord Injury on Female Sexual Response

for
Female Sexual Dysfunction, Multiple Sclerosis,
Location: Birmingham AL
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: Female

Age: 18 - 55

Code: NCT00142714

Recruiting

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

for
Relapsing-remitting Multiple Sclerosis,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: Female

Age: 18 - 55

Code: NCT01466114

Phase2, Recruiting

A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis

for
Multiple Sclerosis
Location: Philadelphia PA
Sponsor: Multiple Sclerosis Institute

Sex: All

Age: 18 - 55

Code: NCT00217295

Phase2, Recruiting

Novel Immune Markers in Patients With Multiple Sclerosis

for
Multiple Sclerosis
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 21 - 50

Code: NCT01026272

Recruiting

A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

for
Relapsing Remitting Multiple Sclerosis
Location: Birmingham AL
Sponsor: Alabama Neurology Associates, PC

Sex: All

Age: 18 - 55

Code: NCT00242268

Phase3, Recruiting

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

for
Relapsing Remitting Multiple Sclerosis (RRMS)
Location: St. John's, Halifax, Montreal, Sherbrooke, Quebec,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06733922

Recruiting

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

for
Multiple Sclerosis, Relapsing-Remitting
Location: New York NY
Sponsor: Transparency Life Sciences

Sex: All

Age: 18 - 64

Code: NCT02369926

Phase2, Recruiting

Clinical Applications of Advanced Ophthalmic Imaging

for
Multiple Sclerosis, Dry Eye Syndromes, Diabetic Retinopathy,
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18 - 70+

Code: NCT03135327

Recruiting

Low Fat Diet for Fatigue in MS

for
Multiple Sclerosis
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 70

Code: NCT03322982

Recruiting

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

for
Multiple Sclerosis
Location: Teaneck NJ, Raleigh NC, West Palm Beach FL,
Sponsor: Sanofi

Sex: All

Age: 18 - 60

Code: NCT07325292

Phase3, Recruiting